Mustang Bio, Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Cover
- Document and Entity Information
Financial Statements
Notes to Financial Statements
Accounting Policies
- Significant Accounting Policies (Policies)
Notes Tables
Notes Details

Clinical Trial and Sponsored Research Agreements (City of Hope - Sponsored Research and Clinical Trial Agreements) (Narrative) (Details)

v3.24.3

Clinical Trial and Sponsored Research Agreements (City of Hope - Sponsored Research and Clinical Trial Agreements) (Narrative) (Details) - USD ($) $ in Thousands		1 Months Ended							3 Months Ended		9 Months Ended
	Jul. 03, 2017	Jun. 30, 2024	Apr. 30, 2024	Nov. 30, 2022	Jan. 31, 2022	Nov. 30, 2020	Oct. 31, 2020	Feb. 28, 2017	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
License, Clinical Trial and Sponsored Research Agreements
Research and development expense									$ 57	$ 9,527	$ 8,221	$ 34,363
Research and development
License, Clinical Trial and Sponsored Research Agreements
Forgiveness of all amounts previously owed											$ 900
Mayo Clinic
License, Clinical Trial and Sponsored Research Agreements
Forgiveness of all amounts previously owed		$ 300
St. Jude Children's Research Hospital
License, Clinical Trial and Sponsored Research Agreements
Forgiveness of all amounts previously owed			$ 600
IL13Ra2 CAR and (C134)
License, Clinical Trial and Sponsored Research Agreements
Research and development expense				$ 600			$ 300
Clinical trial and sponsored research agreements \| IL13Ra2 (MB-101) \| City of Hope National Medical Center
License, Clinical Trial and Sponsored Research Agreements
Contribution toward patient costs								$ 100
Contribution per patient							100
Annual maintenance fee payable							$ 200
Clinical trial and sponsored research agreements \| CD20 (MB-106) \| Fred Hutchinson Cancer Center
License, Clinical Trial and Sponsored Research Agreements
Contribution toward patient costs						$ 800
Milestones payable	$ 5,300
Additional milestone payments					$ 2,200	$ 1,800
Clinical trial and sponsored research agreements \| CD20 (MB-106) \| Fred Hutchinson Cancer Center \| Maximum
License, Clinical Trial and Sponsored Research Agreements
Additional milestone payments					$ 9,300

- Definition

The amount of additional milestones payable under the arrangement.

+ References

No definition available.

+ Details

Name:	mbio_AdditionalMilestonesPayableUnderArrangement
Namespace Prefix:	mbio_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

The amount of annual maintenance fee payable under the arrangement.

+ References

No definition available.

+ Details

Name:	mbio_AnnualMaintenanceFeePayable
Namespace Prefix:	mbio_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

The amount of contribution to be paid toward patient costs.

+ References

No definition available.

+ Details

Name:	mbio_ContributionTowardPatientCosts
Namespace Prefix:	mbio_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

The amount of milestones payable under the arrangement.

+ References

No definition available.

+ Details

Name:	mbio_MilestonesPayableUnderArrangement
Namespace Prefix:	mbio_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

The amount of contribution to be paid per patient under the arrangement.

+ References

No definition available.

+ Details

Name:	mbio_ResearchArrangementContributionPerPatient
Namespace Prefix:	mbio_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 808
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479402/808-10-50-1

+ Details

Name:	us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

- Definition

Decrease for amounts of indebtedness forgiven by the holder of the debt instrument.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 235
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(f))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1

+ Details

Name:	us-gaap_DebtInstrumentDecreaseForgiveness
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

Amount of expense for research and development. Excludes cost for computer software product to be sold, leased, or otherwise marketed, writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both, and write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 730
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482916/730-10-50-1

+ Details

Name:	us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Details

Name:	us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_CounterpartyNameAxis=mbio_MayoClinicMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_CounterpartyNameAxis=mbio_St.JudeChildrensResearchHospitalMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_ProductOrServiceAxis=mbio_Il13ra2CarAndC134Member
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_TypeOfArrangementAxis=mbio_ClinicalTrialAndSponsoredResearchAgreementsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_ProductOrServiceAxis=mbio_Il13r2ProductMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_CounterpartyNameAxis=mbio_CityOfHopeNationalMedicalCenterCohMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_ProductOrServiceAxis=mbio_Cd20TechnologyProductOrProcessMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_CounterpartyNameAxis=mbio_FredHutchinsonCancerResearchCenterMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_RangeAxis=srt_MaximumMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type: